DANIEL IRIZARRY, M.D.
Family Medicine Physician in ALTAMONTE SPRINGS, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
DANIEL IRIZARRY, M.D. reported a CMS MIPS final score of 93.2958/100 — above the 83.1 national average — and filed 2,962 Medicare Part D claims in 2023.
- 93.2958/100
- MIPS score · +10 vs avg
- 3K
- Part D claims, 2023
- 87%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
DANIEL IRIZARRY, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
93 Top 29% higher than 71% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
DANIEL IRIZARRY, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about DANIEL IRIZARRY, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Florida
How Family Medicine Physician compares to other specialties among Florida providers
Family Medicine Physician share within Florida
Family Medicine Physician is one of the more visible NUCC categories in Florida
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
DANIEL IRIZARRY, M.D.'s 2023 MIPS final score plotted against the Family Medicine Physician national average
- MIPS Final Score
- 93.2958/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Family Medicine Physician) — 93.2958/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Family Medicine Physician US NPIs
93.2958/100 MIPS final score — 10.2 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Family Medicine Physician. Quality dim: 86.5916.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
DANIEL IRIZARRY, M.D. appears in the CMS NPPES registry as a Family Medicine Physician provider holding M.D. credentials at 460 E ALTAMONTE DR STE 2200, ALTAMONTE SPRINGS, FL, 32701, with a listed phone of (407) 767-0009. NPI 1477561843 was issued on 08/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what IRIZARRY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,962 prescription claims written by this provider, covering 459 Medicare beneficiaries and totaling roughly $259K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 2.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.2958/100 for the 2023 performance year (Quality 86.5916), compared with the national average of 83.1.
Family Medicine Physician is a high-volume specialty nationwide, with 147,640 enrolled providers across 56 states and an average of 3,418 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1477561843 |
|---|---|
| Specialty | Family Medicine Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/03/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm DANIEL IRIZARRY, M.D.'s current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
License & disciplinary context — Florida FLDOH 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to DANIEL IRIZARRY, M.D.. To verify DANIEL IRIZARRY, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
13% brand-name claims vs 87% generic, on 2,962 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 6,614
- Total Day Supply
- 195,388
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $209K
- Generic Drug Cost
- $49K
- Opioid Claims
- 62 (2.1% rate)
- Antibiotic Claims
- 27
Patient Demographics
- Average Patient Age
- 71.6 years
- Avg HCC Risk Score
- 1.31
- Gender Split
- 51% female / 49% male
- Age Distribution
- <65: 64, 65-74: 230, 75-84: 122, 85+: 43
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What DANIEL IRIZARRY, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
147 claims
- Gabapentin
Gabapentin
126 claims
- Levothyroxine Sodium
Levothyroxine Sodium
124 claims
- Amlodipine Besylate
Amlodipine Besylate
106 claims
- Lisinopril
Lisinopril
87 claims
- Omeprazole
Omeprazole
86 claims
- Losartan Potassium
Losartan Potassium
85 claims
- Metformin Hcl
Metformin Hcl
85 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 147 |
| Gabapentin | 126 |
| Levothyroxine Sodium | 124 |
| Amlodipine Besylate | 106 |
| Lisinopril | 87 |
| Omeprazole | 86 |
| Losartan Potassium | 85 |
| Metformin Hcl | 85 |
| Rosuvastatin Calcium | 75 |
| Alprazolam | 64 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Medicine Physician Overview
How DANIEL IRIZARRY, M.D. fits within the Family Medicine Physician landscape nationally.
DANIEL IRIZARRY, M.D.'s 2,962 claims are below the specialty average of 3,418.
Nearby Family Medicine Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as IRIZARRY.
Compare Family Medicine Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Florida
Frequently Asked Questions
What is DANIEL IRIZARRY, M.D.'s specialty? ▼
How much does DANIEL IRIZARRY, M.D. prescribe under Medicare Part D? ▼
What is DANIEL IRIZARRY, M.D.'s Medicare quality score? ▼
Where is DANIEL IRIZARRY, M.D. located? ▼
What is DANIEL IRIZARRY, M.D.'s NPI number? ▼
Does DANIEL IRIZARRY, M.D. prescribe more brand-name or generic drugs? ▼
Does DANIEL IRIZARRY, M.D. prescribe opioids? ▼
How many Family Medicine Physician providers are there in the US? ▼
What drugs does DANIEL IRIZARRY, M.D. prescribe most often? ▼
Does DANIEL IRIZARRY, M.D. accept Medicare? ▼
How can I verify DANIEL IRIZARRY, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology